What sector does Marker Therapeutics Inc (MRKR) operate in?
Marker Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Marker Therapeutics Inc (MRKR) current stock price?
As of the latest data, Marker Therapeutics Inc stock price is $1.38, with a previous close of $1.39. Marker Therapeutics Inc lost -$0.01 in the last trading session, representing a -0.72% loss.
What is Marker Therapeutics Inc (MRKR) current market capitalization?
Marker Therapeutics Inc market cap is approximately 23.01 million.
What is Marker Therapeutics Inc (MRKR) Earnings Per Share (EPS)?
The trailing EPS is -$1.17, and the forward EPS is -$0.79.
What is Marker Therapeutics Inc (MRKR) EBITDA?
Marker Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.00 million.
Does Marker Therapeutics Inc (MRKR) pay dividends?
No. Marker Therapeutics Inc does not pay a dividend.
How did Marker Therapeutics Inc (MRKR) perform in its most recent earnings report?
In the last report (September 30, 2025), Marker Therapeutics Inc posted an EPS surprise of 42.86% and a revenue surprise of 70.53%.
What is Marker Therapeutics Inc (MRKR) beta (volatility) score?
Marker Therapeutics Inc has a beta of 1.350, suggesting it is more volatile than the market.